V. Evaluation of Cross-Immunity against Type 1 Dengue Fever in Human Subjects Convalescent from Subclinical Natural Japanese Encephalitis Virus Infection and Vaccinated with 17D Strain Yellow Fever Vaccine
VI. Hemagglutination-Inhibiting Antibody Responses to 17D Yellow Fever Vaccine in Human Subjects with Different Degrees of Complexity of Pre-Vaccination Group B Virus Experience
I. Broadened Neutralizing Antibody Spectrum Induced by Strain 17D Yellow Fever Vaccine in Human Subjects Previously Infected with Japanese Encephalitis Virus